Logo image of ACWN.DE

AS CREATION TAPETEN AG (ACWN.DE) Stock Fundamental Analysis

FRA:ACWN - Deutsche Boerse Ag - DE000A1TNNN5 - Common Stock - Currency: EUR

6.4  -0.15 (-2.29%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACWN. ACWN was compared to 32 industry peers in the Household Durables industry. ACWN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACWN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACWN had negative earnings in the past year.
In the past year ACWN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACWN reported negative net income in multiple years.
Of the past 5 years ACWN 4 years had a positive operating cash flow.
ACWN.DE Yearly Net Income VS EBIT VS OCF VS FCFACWN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

1.2 Ratios

With a Return On Assets value of -4.96%, ACWN is not doing good in the industry: 88.57% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -8.03%, ACWN is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -4.96%
ROE -8.03%
ROIC N/A
ROA(3y)-0.98%
ROA(5y)1.85%
ROE(3y)-1.4%
ROE(5y)3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ACWN.DE Yearly ROA, ROE, ROICACWN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

The Gross Margin of ACWN (49.58%) is better than 68.57% of its industry peers.
In the last couple of years the Gross Margin of ACWN has remained more or less at the same level.
ACWN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-0.39%
ACWN.DE Yearly Profit, Operating, Gross MarginsACWN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

ACWN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACWN has about the same amount of shares outstanding.
The number of shares outstanding for ACWN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ACWN has a worse debt to assets ratio.
ACWN.DE Yearly Shares OutstandingACWN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
ACWN.DE Yearly Total Debt VS Total AssetsACWN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

An Altman-Z score of 2.24 indicates that ACWN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACWN has a Altman-Z score of 2.24. This is comparable to the rest of the industry: ACWN outperforms 57.14% of its industry peers.
ACWN has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ACWN (0.11) is better than 91.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACCN/A
WACC5.61%
ACWN.DE Yearly LT Debt VS Equity VS FCFACWN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

ACWN has a Current Ratio of 3.24. This indicates that ACWN is financially healthy and has no problem in meeting its short term obligations.
ACWN's Current ratio of 3.24 is amongst the best of the industry. ACWN outperforms 91.43% of its industry peers.
A Quick Ratio of 1.80 indicates that ACWN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.80, ACWN belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 1.8
ACWN.DE Yearly Current Assets VS Current LiabilitesACWN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

ACWN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.32%.
ACWN shows a decrease in Revenue. In the last year, the revenue decreased by -9.32%.
Measured over the past years, ACWN shows a decrease in Revenue. The Revenue has been decreasing by -2.05% on average per year.
EPS 1Y (TTM)-18.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-373.53%
Revenue 1Y (TTM)-9.32%
Revenue growth 3Y-5.77%
Revenue growth 5Y-2.05%
Sales Q2Q%-8.63%

3.2 Future

The Earnings Per Share is expected to grow by 48.92% on average over the next years. This is a very strong growth
ACWN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.72% yearly.
EPS Next Y-207.89%
EPS Next 2Y56.86%
EPS Next 3Y48.92%
EPS Next 5YN/A
Revenue Next Year-11.99%
Revenue Next 2Y-4.83%
Revenue Next 3Y-1.97%
Revenue Next 5Y0.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACWN.DE Yearly Revenue VS EstimatesACWN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ACWN.DE Yearly EPS VS EstimatesACWN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ACWN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 17.93 indicates a rather expensive valuation of ACWN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACWN indicates a slightly more expensive valuation: ACWN is more expensive than 71.43% of the companies listed in the same industry.
ACWN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 17.93
ACWN.DE Price Earnings VS Forward Price EarningsACWN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACWN is valued a bit more expensive than 77.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.43
ACWN.DE Per share dataACWN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

ACWN's earnings are expected to grow with 48.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.86%
EPS Next 3Y48.92%

More info and screens

0

5. Dividend

5.1 Amount

ACWN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AS CREATION TAPETEN AG

FRA:ACWN (3/5/2025, 7:00:00 PM)

6.4

-0.15 (-2.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-07 2024-11-07
Earnings (Next)03-26 2025-03-26/amc
Inst Owners10.78%
Inst Owner ChangeN/A
Ins Owners59.38%
Ins Owner ChangeN/A
Market Cap17.66M
Analysts85.71
Price Target14.28 (123.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3025%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.93
P/S 0.16
P/FCF N/A
P/OCF 9.83
P/B 0.26
P/tB 0.29
EV/EBITDA 17.43
EPS(TTM)-1.95
EYN/A
EPS(NY)0.36
Fwd EY5.58%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)0.65
OCFY10.17%
SpS41.21
BVpS24.29
TBVpS21.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.96%
ROE -8.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.58%
FCFM N/A
ROA(3y)-0.98%
ROA(5y)1.85%
ROE(3y)-1.4%
ROE(5y)3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-0.39%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 8.66
Cap/Depr 41.06%
Cap/Sales 2.61%
Interest Coverage N/A
Cash Conversion 215.65%
Profit Quality N/A
Current Ratio 3.24
Quick Ratio 1.8
Altman-Z 2.24
F-Score3
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)67.21%
Cap/Depr(5y)74.64%
Cap/Sales(3y)2.77%
Cap/Sales(5y)3.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-373.53%
EPS Next Y-207.89%
EPS Next 2Y56.86%
EPS Next 3Y48.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.32%
Revenue growth 3Y-5.77%
Revenue growth 5Y-2.05%
Sales Q2Q%-8.63%
Revenue Next Year-11.99%
Revenue Next 2Y-4.83%
Revenue Next 3Y-1.97%
Revenue Next 5Y0.72%
EBIT growth 1Y9.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50%
EBIT Next 3Y88.99%
EBIT Next 5YN/A
FCF growth 1Y79.92%
FCF growth 3Y-48.37%
FCF growth 5YN/A
OCF growth 1Y176.27%
OCF growth 3Y-18.58%
OCF growth 5Y2.64%